Anti-Human LAP (TGFB3) Reference Antibody (Brigham and Womens anti-LAP)

Description: Anti-Human LAP (TGFB3) Antibody (Brigham and Womens anti-LAP) (BS12426) is a research-grade recombinant antibody targeting LAP. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality:
Applications: Research Grade Biosimilar
Target: LAP,Transforminggrowthfactorbeta-3proprotein,TGFB3,TGF-beta-3
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names:
Background: Transforming growth factor beta-3 proprotein (LAP (TGFB3)) is a ~47 kDa protein. Transforming growth factor beta-3 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-3 (TGF-beta-3) chains, which constitute the regulatory and active subunit of TGF-beta-3, respectively.
Note: For research use only. Not suitable for clinical or therapeutic use.